Kalypsys, Inc.
1 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| A 2 Week Study of Topical KD7040 in the Treatment of Postherpetic Neuralgia (PHN) (NCT00576108) | Kalypsys, Inc. | 2007-11-01 |
Track Kalypsys, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.